🔎 Trials Near Me

Hjem › Brystkreft › North Carolina › Winston-Salem

Kliniske studier for Brystkreft i Winston-Salem, NC

14 studier for Brystkreft søker deltakere på steder i og rundt Winston-Salem (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

RekruttererFase 3
  • Novant Health Oncology Specialists ( Site 0074), Winston-Salem
Alder 18 og eldre · Alle kjønn · Oppdatert 6. okt. 2026 · NCT07060807

Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial

Rekrutterer
  • Wake Forest NCORP RB, Winston-Salem
Alder 18 til 85 · Alle kjønn · Oppdatert 6. okt. 2026 · NCT07474090

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

RekruttererFase 2
  • Comprehensive Cancer Center at Wake Forest University (CCCWFU), Winston-Salem
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT02422641

Distance-Based Exercise to Preserve Function and Prevent Disability

Rekrutterer
  • Novant Health Forsyth Medical Center, Winston-Salem
  • Novant Health Cancer Institute - Kernersville, Kernersville · 10 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07059884

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

RekruttererFase 3
  • Novant Health Forsyth Medical Center, Winston-Salem
  • Wake Forest University Health Sciences, Winston-Salem
  • Novant Health Colon and Rectal Clinic, Clemmons · 9 mi unna
  • og 2 flere
Alder 18 til 60 · Kvinner · Oppdatert 2. sep. 2026 · NCT05879926

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

RekruttererFase 3
  • Research Site, Winston-Salem
Alder 18 til 130 · Alle kjønn · Oppdatert 19. aug. 2026 · NCT05774951

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

RekruttererFase 2
  • Atrium Health Wake Forest Baptist - Comprehensive Cancer Center, Winston-Salem
Alder 8 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT05503797

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

RekruttererFase 2
  • Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Alder 18 og eldre · Alle kjønn · Oppdatert 6. mai 2026 · NCT01042379

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

RekruttererFase 3
  • Novant Health Forsyth Medical Center, Winston-Salem
  • Wake Forest University Health Sciences, Winston-Salem
  • Wake Forest University at Clemmons, Clemmons · 9 mi unna
  • og 1 flere
Alder 50 til 70 · Alle kjønn · Oppdatert 23. apr. 2026 · NCT04852887

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

RekruttererObservasjonsstudie
  • Wake Forest NCORP Research Base, Winston-Salem
  • Wake Forest University Health Sciences, Winston-Salem
  • Wake Forest University at Clemmons, Clemmons · 9 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 17. mar. 2026 · NCT06418204

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

RekruttererObservasjonsstudie
  • Atrium Health Wake Forest Baptist Medical Center, Winston-Salem
Alder 18 og eldre · Alle kjønn · Oppdatert 20. jan. 2026 · NCT06401421

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RekruttererObservasjonsstudie
  • Massive Bio SYNERGY-AI site, Winston-Salem
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

Brystkreft-studier i andre byer

Andre studier i Winston-Salem

Fra ClinicalTrials.gov, data hentet 7. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.